51 – 60 of 107
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3:08699 affibody molecule
(
- Contribution to journal › Article
-
Mark
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors : preclinical assessment
2014) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 55(11). p.8-1842(
- Contribution to journal › Article
-
Mark
Incorporation of a triglutamyl spacer improves the biodistribution of synthetic affibody molecules radiofluorinated at the N-terminus via oxime formation with (18)F-4-fluorobenzaldehyde
(
- Contribution to journal › Article
- 2013
-
Mark
Stromal EGF and igf-I together modulate plasticity of disseminated triple-negative breast tumors
(
- Contribution to journal › Article
-
Mark
miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts
(
- Contribution to journal › Article
-
Mark
Arkadia regulates tumor metastasis by modulation of the TGF-β pathway
(
- Contribution to journal › Article
-
Mark
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer
(
- Contribution to journal › Article
-
Mark
WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells
(
- Contribution to journal › Article
-
Mark
A modified database search strategy leads to improved identification of in vitro brominated peptides spiked into a complex proteomic sample
(
- Contribution to journal › Article
-
Mark
Cyclophilin D extramitochondrial signaling controls cell cycle progression and chemokine-directed cell motility
(
- Contribution to journal › Article